BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25275248)

  • 1. Rho kinase inhibition mitigates sunitinib-induced rise in arterial pressure and renal vascular resistance but not increased renal sodium reabsorption.
    Grisk O; Koenen A; Meissner T; Donner A; Braun D; Steinbach A; Glöckl G; Zimmermann U; Evert K; Evert M; Katsari E; Löhn M; Plettenburg O; Rettig R
    J Hypertens; 2014 Nov; 32(11):2199-210; discussion 2110. PubMed ID: 25275248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension.
    Thijs AM; van Herpen CM; Verweij V; Pertijs J; van den Broek PH; van der Graaf WT; Rongen GA
    J Hypertens; 2015 Oct; 33(10):2075-82. PubMed ID: 26203967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of distal tubule and collecting duct sodium reabsorption in sunitinib-induced hypertension.
    Witte J; Lampe J; Koenen A; Urbaneck I; Steinbach A; Rettig R; Grisk O
    J Hypertens; 2018 Apr; 36(4):892-903. PubMed ID: 29283974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels.
    Kappers MH; van Esch JH; Sluiter W; Sleijfer S; Danser AH; van den Meiracker AH
    Hypertension; 2010 Oct; 56(4):675-81. PubMed ID: 20733093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats.
    Gu JW; Manning RD; Young E; Shparago M; Sartin B; Bailey AP
    Am J Physiol Regul Integr Comp Physiol; 2009 Jul; 297(1):R142-8. PubMed ID: 19420288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors.
    León-Mateos L; Mosquera J; Antón Aparicio L
    Redox Biol; 2015 Dec; 6():421-425. PubMed ID: 26386874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Soluble Guanylate Cyclase Is Downregulated in Sunitinib-Induced Hypertension.
    Witte J; Mühlbauer M; Braun D; Steinbach A; Golchert J; Rettig R; Grisk O
    J Am Heart Assoc; 2018 Sep; 7(18):e009557. PubMed ID: 30371202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high salt diet on blood pressure and renal damage during vascular endothelial growth factor inhibition with sunitinib.
    Lankhorst S; Baelde HJ; Clahsen-van Groningen MC; Smedts FM; Danser AH; van den Meiracker AH
    Nephrol Dial Transplant; 2016 Jun; 31(6):914-21. PubMed ID: 26681729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salt Sensitivity of Angiogenesis Inhibition-Induced Blood Pressure Rise: Role of Interstitial Sodium Accumulation?
    Lankhorst S; Severs D; Markó L; Rakova N; Titze J; Müller DN; Danser AH; van den Meiracker AH
    Hypertension; 2017 May; 69(5):919-926. PubMed ID: 28320855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vascular endothelial growth factor receptor inhibitor sunitinib causes a preeclampsia-like syndrome with activation of the endothelin system.
    Kappers MH; Smedts FM; Horn T; van Esch JH; Sleijfer S; Leijten F; Wesseling S; Strevens H; Jan Danser AH; van den Meiracker AH
    Hypertension; 2011 Aug; 58(2):295-302. PubMed ID: 21670421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertension.
    Eechoute K; van der Veldt AA; Oosting S; Kappers MH; Wessels JA; Gelderblom H; Guchelaar HJ; Reyners AK; van Herpen CM; Haanen JB; Mathijssen RH; Boven E
    Clin Pharmacol Ther; 2012 Oct; 92(4):503-10. PubMed ID: 22948895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
    Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
    Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater Sensitivity of Blood Pressure Than Renal Toxicity to Tyrosine Kinase Receptor Inhibition With Sunitinib.
    Lankhorst S; Baelde HJ; Kappers MH; Smedts FM; Hansen A; Clahsen-van Groningen MC; Sleijfer S; Mathijssen RH; Danser AH; van den Meiracker AH
    Hypertension; 2015 Sep; 66(3):543-9. PubMed ID: 26195484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome.
    Kapiteijn E; Brand A; Kroep J; Gelderblom H
    Ann Oncol; 2007 Oct; 18(10):1745-7. PubMed ID: 17890216
    [No Abstract]   [Full Text] [Related]  

  • 15. The Rho kinase inhibitor SAR407899 potently inhibits endothelin-1-induced constriction of renal resistance arteries.
    Grisk O; Schlüter T; Reimer N; Zimmermann U; Katsari E; Plettenburg O; Löhn M; Wollert HG; Rettig R
    J Hypertens; 2012 May; 30(5):980-9. PubMed ID: 22388233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study.
    Lankhorst S; Kappers MH; van Esch JH; Smedts FM; Sleijfer S; Mathijssen RH; Baelde HJ; Danser AH; van den Meiracker AH
    Hypertension; 2014 Dec; 64(6):1282-9. PubMed ID: 25185126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.
    Bollée G; Patey N; Cazajous G; Robert C; Goujon JM; Fakhouri F; Bruneval P; Noël LH; Knebelmann B
    Nephrol Dial Transplant; 2009 Feb; 24(2):682-5. PubMed ID: 19054798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma.
    Rautiola J; Donskov F; Peltola K; Joensuu H; Bono P
    BJU Int; 2016 Jan; 117(1):110-7. PubMed ID: 25252180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotic symptoms in the course of sunitinib treatment for advanced renal cell cancer. Two cases.
    Schellekens AF; Mulder SF; van Eijndhoven PF; Smilde TJ; van Herpen CM
    Gen Hosp Psychiatry; 2011; 33(1):83.e1-3. PubMed ID: 21353137
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment Of Sunitinib-Induced Hypertension In Solid Tumors By Nitric Oxid Donors.
    Leon LA; Antón-Aparicio LM
    Redox Biol; 2015 Aug; 5():422. PubMed ID: 28162293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.